Remón RL, Uvidia CG, Castro HOJ

Language: Spanish
References: 10
Page: 67-72
PDF size: 668.19 Kb.

ABSTRACT

The case report of a 52 years patient is presented, exposed to the ashes of Tungurahua volcano in eruption, who went to the Community Family Medicine Department of the Canton Guano, Ecuadorian province of Riobamba, for presenting productive cough in the morning, mucoid of yellowish white coloration, bad general state, evening fever, appetite and weight loss. According to the radiographic and topographic results, he had suggestive signs of lung tuberculosis; direct BAAR sputa and negative cultures. The pathological findings allowed to confirm the diagnosis of idiopathic lung fibrosis.

REFERENCES

1. Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet. 2011; 377(9779):1760-9.

2. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011; 183(6):788-824.

3. Raghnu G, Anstrom KJ, Durham NC, King TE, Lasky JA, Martínez FJ. Prednisone, azathriopine and n-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012; 366:1968–77.

4. Richeldi L, Du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014; 370: 2071-82.

5. Papakosta D, Dimadi M, Stagaki E. Prevalence of pulmonary arterial hypertension in idiophatic pulmonary fibrosis: a multicenter study. 9 th Wasog Meeting & 11 th BAL Internacional Conference. Athens, Greece PP71; 2008: 114.

6. Olson AL, Huie TJ, Groshong SD, Cosgrove GP, Janssen WJ, Schwarz MI, et al. Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series. Chest. 2008; 134(4): 844-50.

7. Xaubet A, Molina Molina M, Sánchez M. Enfermedades pulmonares intersticiales difusas. Arch Bronconeumol. 2007; 43(Supl 2): 24-30.

8. Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis. 2008; 3:8.

9. García Sancho C, Buendía Roldán I, Fernández Plata MR, Navarro C, Pérez Padilla R, Vargas MH, et al. Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis. Respir Med. 2011; 105(12): 1902-7.

10. Bradley B, Branley HM, Egan JJ, Graves MS, Hansell DM, Harrison K. Interstitial lung disease guideline: The British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax. 2008; 63 (Suppl 5): v1-58.